RxDoctor Payments Data

Michelle Moore, APRN

Family · Danbury, CTNPI 1255984043

Payments from drug & device makers

$4,865in general payments, 2019–2025

Across 117 payments — averaging $41.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$1K
  • Seagen Inc.$941
  • AbbVie$495
  • Incyte Corporation$391
  • Johnson & Johnson$234
  • Pfizer$202
  • plus $2K from 28 others

What the payments were for

  • Food & beverage$2,03942%
  • Education$2,82758%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,865 in reported general payments places this provider in the 90th percentile of 1,596 family providers in Connecticut.

See all family providers in Connecticut

Medicare billing

Part B allowed, 2024
$64,004
Medicare patients
344
Services billed
772

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban20$13,177
PaxlovidNirmatrelvir/Ritonavir13$1,429
Albuterol Sulfate HfaAlbuterol Sulfate24$396
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav34$262
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst23$235
Losartan Potassium32$163
Prednisone28$105
Amlodipine Besylate26$92
Fluconazole12$64
Atorvastatin Calcium20$61
Anastrozole16$58
Azithromycin12$55
Doxycycline Hyclate14$40

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$234$13,17720 claims
PfizerPaxlovid$202$1,42913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,596 family providers in Connecticut.

Other family in Danbury

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →